Premium
Common genetic variants in candidate genes and risk of familial lymphoid malignancies
Author(s) -
Liang Xueying Sharon,
Caporaso Neil,
McMaster Mary Lou,
Ng David,
Landgren Ola,
Yeager Meredith,
Chanock Stephen,
Goldin Lynn R.
Publication year - 2009
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2009.07790.x
Subject(s) - chronic lymphocytic leukemia , genetics , biology , germline , allele , lymphoma , gene , single nucleotide polymorphism , immunology , family aggregation , leukemia , medicine , genotype , disease
Summary Familial aggregation, linkage and case–control studies support the role of germline genes in the aetiology of lymphoid malignancies. To further examine the role of genetic variation underlying susceptibility, we analysed 1536 single nucleotide polymorphisms in 152 genes involved in apoptosis, DNA repair, immune response and oxidative stress pathways among a unique sample of 165 unrelated familial cases including patients with chronic lymphocytic leukaemia (CLL), Waldenström macroglobulinaemia (WM) and Hodgkin lymphoma (HL), and 107 spouse controls. We confirmed previous studies showing a polymorphism in the IL10 promoter (rs1800890/‐3575T>A) to be associated with non‐Hodgkin lymphoma, as this allele was found to be associated with both CLL and WM. We also confirmed the role of IL6 variation to be associated with HL. Polymorphisms in TNFSF10 were associated with both CLL and WM. Future replication and functional studies are needed to clarify the role of these genetic variants. Finally, our data further support the close association of WM and CLL.